FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005514586> ?p ?o ?g. }

• W2005514586 endingPage "2105" @default.
• W2005514586 startingPage "2099" @default.
• W2005514586 abstract "Background Total shoulder arthroplasty (TSA) is an effective treatment for end-stage glenohumeral joint pathology with good long-term results. Previous descriptions of morbidity and blood transfusion in TSA are limited by preoperative risk factors and postoperative complications considered and single-center studies. Questions/purposes The purpose of this study was to define in a group of patients undergoing TSA (1) the type and incidence of complications; (2) the frequency of and risk factors for both minor and major complications; and (3) the risk factors for bleeding resulting in transfusion. Methods We retrospectively queried the National Surgical Quality Improvement Program database using Current Procedural Terminology billing codes and identified 1922 cases of TSA performed between 2006 and 2011. Postoperative outcomes were divided into one of four categories: any complication, major morbidity (systemic life-threatening event or a substantial threat to a vital organ) or mortality, minor morbidity (localized to the operative upper extremity or not posing a major systemic threat to the patient), or bleeding resulting in transfusion. Univariate and multivariate analyses were then used to identify risk factors for complications. Results There were a total of 155 complications (8% of the 1922 patients identified). The most common complication was bleeding resulting in transfusion (82 patients [4.26%]) followed by urinary tract infections (27 patients [1.40%]), return to the operating room (14 patients [0.73%]), pneumonia (10 patients [0.52%]), and peripheral nerve injury (nine patients [0.47%]). The incidence of major morbidity was 2% (44 patients), which included five patients (0.26%) who died; the incidence of any minor morbidity was 7% (136 patients). After controlling for likely confounding variables, we found steroid use (odds ratio [OR], 3; 95% confidence interval [CI], 2-6), hematocrit < 38% (OR, 2; 95% CI, 1-3), American Society of Anesthesiologists (ASA) Class 4 (OR, 3; 95% CI, 1-7), and operating time > 2 hours (OR, 2; 95% CI, 1-3) as independent predictors of complication and congestive heart failure (OR, 12; 95% CI, 1-106) as an independent risk factor for major morbidity or mortality. Hematocrit < 38% (OR, 3; 95% CI, 2-6), resident involvement (OR, 3; 95% CI, 2-5), steroid use (OR, 3; 95% CI, 1-6), and ASA Class 3 versus 1 or 2 (OR, 2; 95% CI, 1-5) were independent risk factors for bleeding resulting in transfusion. Conclusions Short-term morbidity after TSA is higher than previously reported. The prevalence of complications within 30 days of surgery and our outlined risk factors should guide surgeon-driven preoperative patient evaluation, management, and counseling. Surgeons who perform TSA should be aware operative time > 2 hours is associated with increased complications. Patients with preoperative hematocrit < 38%, history of steroid use, ASA Class > 2, and patients with congestive heart failure should receive medical optimization before TSA. Level of Evidence Level III, therapeutic study." @default.
• W2005514586 created "2016-06-24" @default.
• W2005514586 creator A5014585603 @default.
• W2005514586 creator A5043081048 @default.
• W2005514586 creator A5061638494 @default.
• W2005514586 creator A5079032277 @default.
• W2005514586 creator A5087323863 @default.
• W2005514586 creator A5089633244 @default.
• W2005514586 date "2015-06-01" @default.
• W2005514586 modified "2023-10-18" @default.
• W2005514586 title "What Are Risk Factors for 30-day Morbidity and Transfusion in Total Shoulder Arthroplasty? A Review of 1922 Cases" @default.
• W2005514586 cites W1522868684 @default.
• W2005514586 cites W1831759197 @default.
• W2005514586 cites W1908060106 @default.
• W2005514586 cites W1948713634 @default.
• W2005514586 cites W1967884169 @default.
• W2005514586 cites W1971002392 @default.
• W2005514586 cites W1973027762 @default.
• W2005514586 cites W1977149018 @default.
• W2005514586 cites W1978134938 @default.
• W2005514586 cites W1978375149 @default.
• W2005514586 cites W1982482254 @default.
• W2005514586 cites W1982686470 @default.
• W2005514586 cites W1983531637 @default.
• W2005514586 cites W1985962162 @default.
• W2005514586 cites W1995018051 @default.
• W2005514586 cites W2010112662 @default.
• W2005514586 cites W2013402714 @default.
• W2005514586 cites W2013473827 @default.
• W2005514586 cites W2022965529 @default.
• W2005514586 cites W2024896644 @default.
• W2005514586 cites W2029004615 @default.
• W2005514586 cites W2030237847 @default.
• W2005514586 cites W2031867490 @default.
• W2005514586 cites W2036560294 @default.
• W2005514586 cites W2039420293 @default.
• W2005514586 cites W2039631058 @default.
• W2005514586 cites W2040436811 @default.
• W2005514586 cites W2045588275 @default.
• W2005514586 cites W2046628683 @default.
• W2005514586 cites W2054126234 @default.
• W2005514586 cites W2072669092 @default.
• W2005514586 cites W2074594135 @default.
• W2005514586 cites W2076609690 @default.
• W2005514586 cites W2082726001 @default.
• W2005514586 cites W2086627416 @default.
• W2005514586 cites W2094404746 @default.
• W2005514586 cites W2098313313 @default.
• W2005514586 cites W2117195641 @default.
• W2005514586 cites W2119886019 @default.
• W2005514586 cites W2122736223 @default.
• W2005514586 cites W2125553391 @default.
• W2005514586 cites W2127489426 @default.
• W2005514586 cites W2141218183 @default.
• W2005514586 cites W2153366158 @default.
• W2005514586 cites W2254753458 @default.
• W2005514586 cites W2311561700 @default.
• W2005514586 cites W2409466597 @default.
• W2005514586 cites W4231233676 @default.
• W2005514586 doi "https://doi.org/10.1007/s11999-014-4107-7" @default.
• W2005514586 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4419001" @default.
• W2005514586 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25524429" @default.
• W2005514586 hasPublicationYear "2015" @default.
• W2005514586 type Work @default.
• W2005514586 sameAs 2005514586 @default.
• W2005514586 citedByCount "94" @default.
• W2005514586 countsByYear W20055145862015 @default.
• W2005514586 countsByYear W20055145862016 @default.
• W2005514586 countsByYear W20055145862017 @default.
• W2005514586 countsByYear W20055145862018 @default.
• W2005514586 countsByYear W20055145862019 @default.
• W2005514586 countsByYear W20055145862020 @default.
• W2005514586 countsByYear W20055145862021 @default.
• W2005514586 countsByYear W20055145862022 @default.
• W2005514586 countsByYear W20055145862023 @default.
• W2005514586 crossrefType "journal-article" @default.
• W2005514586 hasAuthorship W2005514586A5014585603 @default.
• W2005514586 hasAuthorship W2005514586A5043081048 @default.
• W2005514586 hasAuthorship W2005514586A5061638494 @default.
• W2005514586 hasAuthorship W2005514586A5079032277 @default.
• W2005514586 hasAuthorship W2005514586A5087323863 @default.
• W2005514586 hasAuthorship W2005514586A5089633244 @default.
• W2005514586 hasBestOaLocation W20055145861 @default.
• W2005514586 hasConcept C120665830 @default.
• W2005514586 hasConcept C121332964 @default.
• W2005514586 hasConcept C126322002 @default.
• W2005514586 hasConcept C141071460 @default.
• W2005514586 hasConcept C2777914695 @default.
• W2005514586 hasConcept C2778336525 @default.
• W2005514586 hasConcept C2779513377 @default.
• W2005514586 hasConcept C2780014101 @default.
• W2005514586 hasConcept C50440223 @default.
• W2005514586 hasConcept C61511704 @default.
• W2005514586 hasConcept C71924100 @default.
• W2005514586 hasConcept C81182388 @default.
• W2005514586 hasConceptScore W2005514586C120665830 @default.
• W2005514586 hasConceptScore W2005514586C121332964 @default.
• W2005514586 hasConceptScore W2005514586C126322002 @default.

• next